Arrowhead Pharmaceuticals, Inc. ( ARWR) - Stock Earnings
ARWR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 30.8 million USD | 264.0 million USD |
| 2026Q1 | -132.7 million USD | 73.7 million USD |
| 2026Q2 | -194.3 million USD | 75.3 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
ARWR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -205.3 million USD | 240.7 million USD |
| 2024 | -599.5 million USD | 3.6 million USD |
| 2025 | -1.6 million USD | 829.4 million USD |
| 2026 Est. | — | — |
ARWR
Price: $64.98
52 week price:
Earnings Per Share: -2.28 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 594870
Ebitda: -12.7 millionMarket Capitalization: 12.2 billion